Full-Time

Senior Scientist

Altos Labs

Altos Labs

501-1,000 employees

Biotech startup advancing cellular rejuvenation therapies

Compensation Overview

$179.4k - $330k/yr

California, USA

In Person

Category
AI & Machine Learning (2)
,
Required Skills
LLM
Python
Neural Networks
Pytorch

Get referred to Altos Labs

Find people who can refer or advise you

Requirements
  • PhD in Computer Science, Machine Learning, or a similar quantitative field with 5+ years of relevant work experience in academic or industry settings
  • Prior experience in developing and implementing novel generative AI models, specifically in multimodal integration, GraphRAG, or relational deep learning
  • Deep understanding of Machine Learning principles and how they apply to diverse architectures like Transformers, Graph Neural Networks, and diffusion models
  • Very strong programming skills in Python and deep learning libraries (e.g., PyTorch, JAX, Hugging Face Transformers/Accelerate)
  • Proven experience with multi-GPU and distributed training at scale (e.g., DDP, FSDP, DeepSpeed, Megatron, or Ray)
  • Strong track record of published, peer-reviewed innovative AI/ML research at top-tier conferences (NeurIPS, ICML, ICLR, CVPR)
Responsibilities
  • Pre-train and fine-tune large-scale machine learning systems using multimodal biological data, natural language, and structured relational inputs
  • Architect and implement novel hybrid models that integrate Large Language Models with Graph Neural Networks for multi-hop reasoning over biological knowledge graphs
  • Develop Relational Foundation Models that enable zero-shot predictive tasks over heterogeneous, multi-table biological datasets
  • Lead the design of efficient data loading strategies and distributed training recipes (e.g., FSDP, DeepSpeed) to train models across multiple GPU nodes
  • Gain insights into model performance based on theory, deep research, and the mathematical underpinnings of set-invariant and graph-structured architectures
  • Apply strong coding experience to model development and deployment, ensuring research prototypes transition into reliable, scalable production systems
  • Stay up-to-date on the latest developments in deep learning—including native early-fusion and Mixture-of-Experts architectures—and apply this knowledge to Altos' research
  • Mentor junior staff while maintaining a high individual technical contribution to the core research ecosystem and peer-reviewed publications
Desired Qualifications
  • Familiarity with tabular foundation models (e.g., TabPFN) and in-context learning strategies for structured data
  • Specific experience in native multimodal modeling (early-fusion) or the synthesis of LLMs and Knowledge Graphs
  • Track record of ML applied to biological data, such as NGS data (RNA-seq, ATAC-seq), biological imaging (microscopy, IF), or spatial transcriptomics
  • Experience in optimizing large-scale inference via quantization, distillation, or memory-efficient attention mechanisms

Altos Labs focuses on cell rejuvenation research to restore cellular health and resilience, with the aim of reversing diseases, injuries, and disabilities by programming cells to resist stressors that cause illness. It advances biotech R&D in cellular rejuvenation, producing treatments that can be commercialized for healthcare providers or patients and likely collaborates with research institutions and pharma partners. Unlike purely diagnostic firms, Altos Labs centers on developing breakthrough cellular therapies and regenerative strategies grounded in research, seeking to improve long-term health outcomes. Its goal is to translate cellular rejuvenation science into practical treatments that extend healthspan and reverse disease processes.

Company Size

501-1,000

Company Stage

Early VC

Total Funding

$3.3B

Headquarters

Los Altos, California

Founded

2021

Get referred to Altos Labs

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Appointed Dr. Joan Mannick as CMO to launch clinical trials.
  • $3 billion funding from Jeff Bezos enables rapid R&D scaling.
  • Acquired Stanford-rooted biotech to bolster aging-stopping pipeline.

What critics are saying

  • Calico Labs advances AI-driven programs, eroding first-mover edge.
  • FDA rejection of Rejuvenate Bio's therapy heightens scrutiny.
  • Yamanaka toxicity in primate trials forces reprogramming redesign.

What makes Altos Labs unique

  • Altos Labs pioneers cellular rejuvenation programming using Yamanaka factors.
  • Operates Institutes in San Francisco, San Diego, and Cambridge, UK.
  • Focuses on reversing disease via partial reprogramming, not full iPSCs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
Longevity.Technology
Aug 5th, 2025
Is Altos Labs gearing up for clinical trials?

Longevity biotech giant Altos Labs has appointed Dr Joan Mannick as its Chief Medical Officer and head of product development, signaling a shift toward advancing clinical programs based on the company's cellular rejuvenation technology.

The Business Journals
May 21st, 2025
Jeff Bezos-backed, lifespan-focused Altos Labs buys small biotech with Stanford roots

Altos Labs, backed by $3 billion from Jeff Bezos and others, has snagged a small Peninsula company focused on one approach to stopping aging

The Spirits Business
Mar 27th, 2024
Altos is UK off-trade's leading 100% agave Tequila

In London, Altos recently launched its inaugural Margarita Masters competition for bartenders, with the hope of taking it nationwide in the future.

Startup Italia
Nov 17th, 2023
«Ad Altos Labs Vogliamo Creare Una Nuova Medicina». Simone Bianco E L’Avventura Nella Venture Californiana

«Per uno scienziato Elon Musk ha senz’altro meno appeal di un Premio Nobel». Se poi i Nobel sono quattro, tutti seduti nel board of directors della startup per cui lavori, potremmo dire non esserci partita. Tra questi, ad esempio, Jennifer Doudna, che ha vinto grazie al lavoro sull’editing genetico Crispr nel 2020. Simone Bianco, employee numero 27 di Altos Labs con sede a San Francisco, è Principal Investigator e Director of Computational Biology in quella che lui preferisce definire una venture, non una startup. Nel corso dell’intervista gli abbiamo chiesto di Musk e dei suoi piani per salvare l’umanità, anche con Neuralink, ma la discussione ha rapidamente virato verso altre figure, più specializzate nella materia in questione. Altos Labs, dunque

The Recursive
Mar 8th, 2023
Finding The Fountain Of Youth: Meet The Startups Pioneering Longevity Solutions

If technology allowed humanity to live forever in the future, would you take the ticket? We asked our readers recently and were surprised to see the balance tilt towards “No” (60% of respondents). One answer was hidden in a comment from one of our readers – they would want to live forever, yet only if they stayed young. Among others, living long worries people as it is associated with getting old and suffering from various diseases.Yet if technology allows us to extend our life spans it will also likely improve our health spans. According to demographers, children today have a better chance of living up to 100 years old than ever before. But their lives won’t be just longer, they will also benefit from day-to-day technological advances aimed at improving their well-being, preventing diseases, and keeping their minds and bodies in shape.Slowing aging presents an economic opportunity, too. In the US, an estimate shows that just one to two years increase in life expectancy are worth between $7 trillion and $38 trillion